|
Research Management and Support
|
RMS2008
|
$336,082,664
|
$108,000
|
N/A
|
National Cancer Institute
|
|
WNT Receptor Signaling and Cancer
|
5R01CA071672-12
|
$384,540
|
$384,540
|
AARONSON, STUART
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
Training Program in Cancer Biology
|
5T32CA078207-10
|
$443,412
|
$146,326
|
AARONSON, STUART
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
Detection of Melanoma by Canine Olfactory Receptors.
|
1R21CA132046-01A1
|
$206,550
|
$206,550
|
Abaffy, Tatjana
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Washington University Small Animal Imaging Resource
|
5U24CA083060-10
|
$633,099
|
$31,655
|
ACKERMAN, JOSEPH
|
WASHINGTON UNIVERSITY
|
|
Regulation of Oncogene-Induced Senescence by Wnt-Signaling
|
1R01CA129334-01A1
|
$323,233
|
$161,617
|
ADAMS, PETER
|
INSTITUTE FOR CANCER RESEARCH
|
|
Signal Transduction Pathways in Melanoma
|
5R01CA118972-02
|
$268,701
|
$268,701
|
AHN, NATALIE
|
UNIVERSITY OF COLORADO AT BOULDER
|
|
Defining the role of Id1 in melanoma development
|
5R01CA107017-05
|
$244,169
|
$244,169
|
ALANI, RHODA
|
JOHNS HOPKINS UNIVERSITY
|
|
Prospective study of farmers and their families (Agricultural health study)
|
Z01 CP010119-02020
|
$1,233,935
|
$61,697
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Clinical Academic Oncologist Training Program
|
5K12CA087718-09
|
$446,225
|
$22,311
|
Albertini, Mark
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S5
|
$3,963,721
|
$198,186
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S6
|
$100,000
|
$5,000
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
CHEMOPREVENTION OF SKIN CANCER PROGRAM PROJECT
|
5P01CA027502-27
|
$3,780,708
|
$756,142
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Translational linkage strategies for DNA vaccines against cancer
|
5F31CA130744-02
|
$40,972
|
$40,972
|
Alonzo, Eric
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Therapeutic approaches that target cancer cell metabolism
|
1K23CA120862-01A2
|
$137,295
|
$96,107
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
Z01 CP010183-00580
|
$179,292
|
$8,965
|
Anderson, William
|
DCEG (NCI)
|
|
Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer
|
1K24CA128953-01A1
|
$161,259
|
$32,252
|
ANTONIA, SCOTT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
The role of antigen-specific CD4+ T cells during immunity to established tumors
|
3K22CA125200-02S1
|
$44,831
|
$44,831
|
Antony, Paul
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
The role of antigen-specific CD4+ T cells during immunity to established tumors
|
5K22CA125200-03
|
$161,730
|
$161,730
|
Antony, Paul
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
B-RAF Regulation of the Cell Cycle in Melanoma
|
1R01CA125103-01A2
|
$287,568
|
$287,568
|
APLIN, ANDREW
|
ALBANY MEDICAL COLLEGE
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-22
|
$1,906,536
|
$19,065
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells
|
Z01 BC 010997
|
$178,059
|
$178,059
|
Avital, Itzhak
|
CCR (NCI)
|
|
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis
|
Z01 BC 011004
|
$89,029
|
$71,224
|
Avital, Itzhak
|
CCR (NCI)
|
|
Isolation and Purification of Cancer Stem Cells Based on Functional Appraoch
|
Z01 BC 011005
|
$178,059
|
$17,806
|
Avital, Itzhak
|
CCR (NCI)
|
|
Anti-Tumor Autoimmunity by lymphopenia T cell Expansion
|
5R01CA109026-04
|
$328,921
|
$328,921
|
BACCALA, ROBERTO
|
SCRIPPS RESEARCH INSTITUTE
|
|
San Juan Minority - Based Community Clinical Oncology Program
|
2U10CA052667-18
|
$787,595
|
$7,876
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
3U10CA037429-24S1
|
$464,405
|
$4,644
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Tumor Banking for the Southwest Oncology Group
|
5U24CA114748-04
|
$1,061,839
|
$106,184
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
7U10CA037429-24
|
$16,768,272
|
$167,683
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Improving the Efficacy of Dendritic Cell Vaccines
|
5P01CA084512-07
|
$985,145
|
$788,116
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
Subpopulations of Human Dendritic Cells
|
5R01CA078846-10
|
$292,811
|
$146,406
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
A Novel Treatment to Target Tumor Mass for Eradicating Metastasis
|
1R43CA130182-01A1
|
$200,435
|
$200,435
|
Bao, Yun
|
BIOCHAIN INSTITUTE, INC.
|
|
Malignant melanoma: Regulation by AP-2 and PAR-1
|
2R01CA076098-09A1
|
$271,063
|
$271,063
|
BAR-ELI, MENASHE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Chemically Programmed Antibodies for Cancer Therapy
|
5R01CA104045-05
|
$294,676
|
$58,935
|
BARBAS, CARLOS
|
SCRIPPS RESEARCH INSTITUTE
|
|
Paul Calabresi Clinical Oncology Award
|
5K12CA088084-09
|
$545,376
|
$109,075
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Biomarker Discovery for the Classification of Melanoma
|
1R01CA131524-01A1
|
$349,865
|
$349,865
|
BASTIAN, BORIS
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-24
|
$1,880,470
|
$18,805
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
Nanoparticle peptide-based therapy for melanoma
|
1R43CA132464-01
|
$166,488
|
$166,488
|
Bedu-Addo, Frank
|
PDS BIOTECHNOLOGY CORPORATION
|
|
The Gulf Coast MBCCOP
|
7U10CA128536-02
|
$539,869
|
$5,399
|
BEEKER, THADDEUS
|
PROVIDENCE HOSPITAL (MOBILE, AL)
|
|
The role of Toll-like receptor 3 in overcoming cancer immunoediting
|
5K22CA122828-02
|
$162,047
|
$16,205
|
Bell, Jessica
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Psychoneuroimmunology-Immunotherapy interactions
|
5R01CA125456-02
|
$182,503
|
$60,226
|
Ben-Eliyahu, Shamgar
|
TEL AVIV UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S1
|
$124,531
|
$2,491
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S2
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S3
|
$49,998
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S4
|
$143,383
|
$2,868
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S5
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-44
|
$11,641,774
|
$232,835
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Geisinger Clinical Oncology Program
|
2U10CA035448-25
|
$599,474
|
$5,995
|
BERNATH, ALBERT
|
WEIS CENTER FOR RESEARCH-GEISINGER CLINC
|
|
Solar Exposure and Melanoma Survival
|
5R01CA112524-04
|
$426,227
|
$426,227
|
BERWICK, MARIANNE
|
UNIVERSITY OF NEW MEXICO
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
Z01 SC 004020
|
$1,350,223
|
$270,045
|
Berzofsky, Jay
|
CCR (NCI)
|
Total relevant funding to Melanoma for this search: $110,789,716
|